v3.26.1
Revenue from Contracts with Customers (Tables)
 9 Months Ended
Jun. 30, 2026
Revenues [Abstract]  
Schedule of Disaggregation of Revenue The following is revenue by significant business line for the three and nine months ended June 30, 2026 and 2025 (in thousands):
Three months ended June 30,Nine months ended June 30,
2026202520262025
Significant Business Line
Multiomics$72,889 $66,235 $203,811 $196,054 
Core Products (1)
47,682 45,663 139,589 143,177 
Sample Repository Services40,607 31,957 111,215 95,398 
Total revenue$161,178 $143,855 $454,615 $434,629 
(1)Core Products are Automated Stores, Cryogenic Systems, Automated Sample Tube, Consumables and Instruments and Controlled Rate Thawing Devices.
Schedule of Remaining Performance Obligations The following table summarizes when the Company expects to transfer control of the remaining performance obligations and recognize the corresponding revenue (in thousands):
As of June 30, 2026
Less than 1 Year
Greater than 1 Year
Total
Remaining performance obligations$53,721 $10,294 $64,015